DOI: 10.1055/s-00023610

Drug Research



Kasichayanula S, Chang M, Hasegawa M. et al.
Pharmacokinetics and pharmacodynamics of dapagliflozin, a novel selective inhibitor of sodium-glucose co-transporter type 2, in Japanese subjects without and with type 2 diabetes mellitus.

Diabetes Obes Metab 2011;
13: 357-365

Bibliographische Angaben herunterladen

Aufrufen in:
Aufrufen in: